Literature DB >> 8074054

Pulmonary hypertension in sickle cell disease.

L L Sutton1, O Castro, D J Cross, J E Spencer, J F Lewis.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8074054     DOI： 10.1016/0002-9149(94)90760-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  35 in total

1.  Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

Authors:  Emilie Bollache; Nadjia Kachenoura; Roberto M Lang; Ankit A Desai; Victor Mor-Avi; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-23       Impact factor: 2.357

2.  Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic.

Authors:  Bryan C Hambley; Rania Abdul Rahman; Maxwell Reback; Mary Ann O'Riordan; Nathan Langer; Robert C Gilkeson; Mahazarin Ginwalla; Jane A Little; Robert Schilz
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

4.  Hemodynamic predictors of mortality in adults with sickle cell disease.

Authors:  Alem Mehari; Shoaib Alam; Xin Tian; Michael J Cuttica; Christopher F Barnett; George Miles; Dihua Xu; Catherine Seamon; Patricia Adams-Graves; Oswaldo L Castro; Caterina P Minniti; Vandana Sachdev; James G Taylor; Gregory J Kato; Roberto F Machado
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

5.  Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.

Authors:  Roberto F Machado; Mark T Gladwin
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

6.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

7.  Rescuing Decrepit Soluble Guanylate Cyclase: A Therapy for Sickle Cell Disease?

Authors:  Paul T Schumacker
Journal:  Am J Respir Cell Mol Biol       Date:  2018-05       Impact factor: 6.914

8.  A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.

Authors:  Zhenning He; J Eric Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

Review 9.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

10.  Use of noninvasive positive pressure ventilation during pregnancy: case series.

Authors:  Mariam A Al-Ansari; Akmal A Hameed; Suhaila E Al-jawder; Hassan M Saeed
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.